Cresilon receives FDA clearance for haemostatic gel technology
[ad_1] Cresilon, a Brooklyn-based biotechnology company focused on haemostatic medical device technologies, has announced that it has been granted 510(k) clearance from the US Food and Drug Administration for Cresilon Haemostatic Gel (CHG).…